Type 2 & other diabetes

A cost‐effectiveness analysis alongside trial of a digital health‐supported and community pharmacy‐based prediabetes management programme ( PRIME Programme) in Malaysia

Diabetes Obes MetabPublished Trial-based cost-effectiveness analysis

Main finding · QALYResult — go to the resultNet gain 0.005 QALY 95% CI −0.017 to 0.026

Authors' conclusion

A community pharmacy-based and digital health-supported lifestyle intervention to manage prediabetes may be cost-effective compared with usual care in Malaysia over a 6-month period.

Study context

Population
Individuals with prediabetes, 13 community pharmacies, Malaysia13 community pharmacies
Participants
91 individuals
Comparison
Digital health-supported, community pharmacy-based lifestyle intervention (PRIME) vs usual care
  • Interventionn = 46
  • Usual caren = 45reference
Outcome
QALY
Follow-up
6 months
Methodological details6-month time horizon, healthcare and societal perspectives, non-parametric bootstrapping
  • 6-month time horizon
  • Healthcare and societal perspectives
  • Non-parametric bootstrapping

Main finding

As reported in the abstract

Net gain

0.005 QALY

95% CI −0.017 to 0.026

By group

Further findings

Incremental costs, intervention vs usual care · 6 months

Incremental healthcare cost (95% CI $5.33 to $6.88)
US$6.10
Incremental societal cost (95% CI $6.03 to $15.35)
$10.69

Incremental cost-effectiveness ratios (ICER) per quality-adjusted life years (QALY) gained and probability of cost-effectiveness · 6 months

ICER per QALY gained, healthcare perspective
$1354
Probability cost-effective, healthcare perspective
69.2%
ICER per QALY gained, societal perspective
$2371
Probability cost-effective, societal perspective
67.7%
Willingness-to-pay threshold (results below it; robust to sensitivity analyses)
$11 845

Original publication

A cost‐effectiveness analysis alongside trial of a digital health‐supported and community pharmacy‐based prediabetes management programme ( PRIME Programme) in Malaysia. Diabetes Obes Metab. Published 24 March 2025. doi:10.1111/dom.16350

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.